Iodide 100

Poland
Brand name Iodide 100
Form tablets
Active substance / Dosage
potassium iodide · 0.1308 mg
Prescription type Prescription only
ATC code
Registration number 100201617
Iodide 100 tablets

Patient Information Leaflet

Jodid 100, 100g tablet
Potassium iodide
Please read this leaflet carefully before taking this medicine, as it contains important information for you.

  • Keep this leaflet, as you may need to read it again.
  • If you have any further questions, please consult your doctor or pharmacist.
  • This medicine has been prescribed for a specific individual. Do not pass it on to others. It may harm them even if their symptoms are the same as yours.
  • If you experience any side effects, including any not listed in this leaflet, tell your doctor or pharmacist. See section 4.

Table of contents

  1. What Jodid 100 is and what it is used for
  2. Important information before taking Jodid 100
  3. How to take Jodid 100
  4. Possible side effects
  5. How to store Jodid 100
  6. Contents of the pack and other information

1. What Jodid 100 is and what it is used for

Adequate intake of iodine is essential for the internal synthesis of thyroid hormones and for the proper development and function of the thyroid gland. Insufficient iodine intake may lead to disease, potentially causing goitre (enlargement/hypertrophy of the thyroid gland), and in severe cases, congenital brain disorders (reduced intelligence). Jodid 100 tablets supply iodine and are indicated for the prevention and treatment of iodine deficiency.

Jodid 100 is used:

  • To prevent the development of goitre due to iodine deficiency, especially during pregnancy and breastfeeding;
  • To prevent recurrent goitre enlargement after discontinuation of thyroid hormone therapy or after surgical removal of goitre caused by iodine deficiency;
  • For the treatment of iodine deficiency-induced goitre in newborns, children, and adolescents.

2. Important information before using Jodid 100

When not to use Jodid 100

  • in overt hyperthyroidism;
  • in occult hyperthyroidism, when iodine doses exceed 150 micrograms per day;
  • in autonomous thyroid adenoma and in the presence of focal or disseminated nodular goitre with autonomous hormone secretion;
  • if the patient is allergic to the active substance or to any of the other ingredients of this medicine (listed in section 6).

Warnings and precautions
Before using the medicine, it must be established whether the patient currently has or has had
hyperthyroidism or nodular goitre in the past.
Before starting iodine treatment, appropriate diagnostic evaluation should be performed to
exclude diffuse or focal autonomous thyroid hormone secretion, because in such cases,
administration of iodine in doses exceeding 150 micrograms per day may induce hyperthyroidism.
Saturation of the thyroid gland with iodine may impair optimal accumulation of radioactive iodine
used for diagnostic or therapeutic purposes. The physician should avoid administering
iodine to the patient before administration of radioactive iodine for diagnostic or therapeutic purposes.

Jodid 100 and other medicines
You should inform your doctor about all medicines currently taken or recently taken, as well as
any medicines you plan to take.

  • Iodine deficiency enhances the response to antithyroid treatment in hyperthyroidism, whereas iodine excess diminishes this response. Therefore, if possible, the physician should discontinue iodine administration before and during treatment of hyperthyroidism.
  • Antithyroid drugs block the organification of iodine in the thyroid gland and therefore may act as goitrogenic agents.
  • Iodine uptake by the thyroid gland is competitively inhibited by substances with a similar trapping mechanism (e.g. perchlorate, which also blocks the internal recycling of iodine) and by non-transported substances such as thiocyanate (at concentrations above 5 mg/dl).
  • Concomitant use of high doses of iodine, which inhibits thyroid hormone secretion, and lithium may promote the development of goitre and hypothyroidism.
  • High doses of potassium iodide in combination with potassium-sparing diuretics may cause hyperkalemia.

Pregnancy and breastfeeding
If the patient is pregnant or breastfeeding, suspects she may be pregnant, or is planning to have a
child, she should consult her doctor before using this medicine.
During pregnancy and breastfeeding, the requirement for iodine increases. Therefore, it is
particularly important to ensure adequate intake of iodine (200 \μg/day). Iodine crosses the placenta and is excreted in breast milk. Iodine intake from dietary supplements should be taken into account. Additional iodine supplementation is not necessary in breastfed newborns.
Due to the high sensitivity of the fetal and neonatal thyroid gland, very high doses of iodine (in the mg range) should be avoided during pregnancy and breastfeeding.
An exception is prophylactic blockade of the thyroid gland with high doses of iodine after nuclear
accidents.

Driving and operating machinery
Iodine does not affect the ability to drive motor vehicles or operate machinery.

Jodid 100 contains lactose
If the patient has previously been diagnosed with intolerance to certain sugars, the patient should
consult their doctor before taking this medicine.

3. How to use Jodid 100

This medicine should always be used as directed by the physician. In case of doubt, consult your doctor or pharmacist.

Recommended dose

Prevention of goitre due to iodine deficiency
Infants and children: 50 – 100 micrograms of iodine/day
Adolescents and adults: 100 – 200 micrograms of iodine/day
Pregnancy and breastfeeding: 200 micrograms of iodine/day

Prevention of recurrent goitre after discontinuation of thyroid hormone therapy or after surgical removal of goitre caused by iodine deficiency
100 – 200 micrograms of iodine/day

Treatment of goitre caused by iodine deficiency
Newborns, children: 100 – 200 micrograms of iodine/day
Adolescents: 200 micrograms of iodine/day

Method of administration
The medicine should be taken after meals with an adequate amount of liquid, i.e. half a glass of water.

Prophylactic use of Jodid usually needs to continue for many years, often for life.

In the treatment of iodine deficiency-induced goitre in newborns, treatment usually lasts 2 to 4 weeks. In children and adolescents, iodine supplementation is usually required for 6 to 12 months, or even longer.

Use of a higher than recommended dose of Jodid 100

  • Symptoms of toxic overdose may include: brownish mucous membranes, vomiting, abdominal pain, and diarrhoea.
  • Dehydration and shock may occur.
  • Oesophageal stricture has been observed in rare cases.
  • Fatalities have occurred only after ingestion of extremely large doses of iodine (30–250 ml of tincture of iodine).
  • Chronic overdose may lead to so-called iodism, with symptoms such as metallic taste in the mouth, rhinitis, conjunctivitis, gastric and bronchial mucosal irritation, skin changes such as blisters, thickening, desquamation of the epidermis, and angioedema. Very rarely, fever, acne, and increased salivation have been reported.

Treatment of acute poisoning consists of gastric lavage, symptomatic treatment of water-electrolyte imbalances, and treatment of shock.

In cases of chronic overdose, discontinuation of iodine is indicated. In iodine-induced hypothyroidism, iodine administration should be stopped and thyroid hormones administered. Iodine-induced hyperthyroidism is treated with antithyroid drugs; in very severe cases, admission to an intensive care unit, plasmapheresis (plasma purification), and sometimes even thyroidectomy (removal of the thyroid gland) may be necessary.

4. Possible adverse reactions

Like all medicines, this medicine can cause adverse reactions, although not everyone will experience them.
When autonomous hormone-producing areas exist in the thyroid gland, overt hyperthyroidism caused by iodine doses exceeding 150 micrograms/day cannot be completely ruled out.
In individuals predisposed to autoimmune thyroid diseases, formation of TPO antibodies (thyroid peroxidase antibodies) is possible.

Reporting of adverse reactions
If any adverse reactions occur, including any adverse reactions not listed in this leaflet, inform your doctor, pharmacist, or nurse. Adverse reactions can also be reported directly to the Department of Monitoring Adverse Drug Reactions at the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products
Al. Jerozolimskie 181C, 02-222 Warsaw
Tel.: + 48 22 49 21 301
Fax: + 48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl

Reporting adverse reactions helps to provide more information on the safety of this medicine.

5. How to store Jodid 100

Do not store above 25°C.
Keep in the outer packaging and protect from light.
Keep the medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the carton after: Expiry (EXP). The expiry date refers to the last day of the stated month.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer in use. This will help protect the environment.

6. Contents of the pack and other information

What Jodid 100 contains

  • The active substance is potassium iodide. Each Jodid 100 tablet contains 130.8 micrograms (μg) of potassium iodide, equivalent to 100 μg of iodine.
  • The other ingredients are: magnesium stearate, microcrystalline cellulose, colloidal anhydrous silica, maize starch, powdered cellulose, monohydrate lactose.

What Jodid 100 looks like and contents of the pack
A round tablet, nearly white in colour, flat on both sides, with a scored line on both sides, bevelled edges and the imprint EM 33.
The tablet can be divided into equal doses.
Jodid 100 is available in packs containing 50 or 100 tablets in a cardboard box.
Not all pack sizes may be marketed.

Marketing Authorisation Holder
Merck Sp. z o.o.
Al. Jerozolimskie 142B
02-305 Warsaw, Poland
Company logo

Manufacturer
Merck Healthcare KGaA
Frankfurter Strasse 250
64293 Darmstadt, Germany